Moneycontrol
HomeNewsBusinessCoronavirus Lockdown | Consumers struggling to get hand-sanitisers, face masks: Nielsen India survey
Trending Topics

Coronavirus Lockdown | Consumers struggling to get hand-sanitisers, face masks: Nielsen India survey

Around 22 percent consumers found ready to eat (noodles,upma) out of stock. A similar percentage of customers did not find salty snacks.

April 20, 2020 / 14:21 IST
Story continues below Advertisement

While hand retailers are facing severe constraints of stock replenishment, customers are finding essentials, salty snacks, dairy products and hygiene items out of stock as well.

The desired category/brand was found to be out of retail stock during shopping trips.This was true even for essentials and hygiene categories.

Story continues below Advertisement

As per the survey conducted by Nielsen India, around 15 percent of consumers found grocery essentials (atta, rice, lentils, pulses, oil, ghee) out of stock and 14 percent found dairy products such as milk, cheese and curd out of stock.

Around 22 percent consumers found ready to eat (noodles, upma etc.) out of stock. A similar percentage of customers did not find salty snacks.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show